Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.
The Federal Circuit affirmed six PTAB decisions that held unpatentable as obvious 79 claims of three Cytiva Bioprocess (“Cytiva”) challenged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback